Our overall goal is to determine the role of hormones and growth factors in the regulation of different phenotypes and oncogene activations in mouse mammary carcinogenesis. One out of nine women in the USA is likely to develop breast cancer during her lifetime. The etiology of breast cancer in women has not been defined. Epidemiological studies indicate that hormones are essential for the growth and differentiation of the breast as well as the development of breast cancer. Hormone related factors such as early age of menarche, late menopause, full term pregnancy at an early age, are associated with and increase or decrease in risk for breast cancer. Breast cancer is characterized as being heterogeneous in morphology, karyotypes, metastatic capabilities, hormone independence or hormone dependence and response to therapy. Taken together these characteristics provide circumstantial evidence that breast cancer must progress by a variety of pathways. The factors involved in the modulation of these cancer pathways have not been defined. We have developed a defined culture system in which the specific hormones present around the time of carcinogen exposure affect the incidence and type of mammary transformants as well as the molecular events that are associated with mammary carcinogenesis. Our working hypothesis is that the initiation of carcinogenesis is modulated by the mitogenic environment around the time of carcinogen treatment. We propose to study the role of hormones and growth factors in our defined culture system on the regulation of the phenotype and oncogene activation in mammary carcinogenesis. We will study the role of hormones and growth factors in regulating the expression of proto-oncogenes, the repair of DNA adducts, their role in selection of transformants, and the interaction of hormones and growth factors in carcinogenesis. Additionally we have cloned a novel transforming gene that is potentially another molecular probe for the analysis of sequential changes in carcinogenesis. Extensive molecular and biological characterization of the gene will be carried out.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063369-04
Application #
2376922
Study Section
Reproductive Endocrinology Study Section (REN)
Project Start
1994-05-01
Project End
1999-02-28
Budget Start
1997-03-01
Budget End
1998-02-28
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Rajkumar, Lakshmanaswamy; Guzman, Raphael C; Yang, Jason et al. (2004) Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 6:R31-7
Rajkumar, L; Guzman, R C; Yang, J et al. (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A 98:11755-9
Tsukamoto, T; Yoo, J; Hwang, S I et al. (2000) Expression of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic changes in the mouse mammary gland. Cancer Lett 149:105-13
Tsukamoto, T; Huang, T; Guzman, R C et al. (1999) Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system. Biochem Biophys Res Commun 265:7-12
Guzman, R C; Yang, J; Rajkumar, L et al. (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A 96:2520-5
Chou, Y C; Guzman, R C; Swanson, S M et al. (1999) Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor. Carcinogenesis 20:677-84
Abrams, T J; Guzman, R C; Swanson, S M et al. (1998) Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res 18:4115-21
Bera, T K; Tsukamoto, T; Panda, D K et al. (1998) Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma. Biochem Biophys Res Commun 248:835-40
Hwang, S; Kuo, W L; Cochran, J F et al. (1997) Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers. Genomics 42:540-2
Swanson, S M; Guzman, R C; Tsukamoto, T et al. (1996) N-Ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-methyl-N-nitrosourea. Cancer Lett 102:159-65

Showing the most recent 10 out of 12 publications